Jane Theaker News Today

To accelerate the development of this diagnostic, UC San Diego contributes over 2,000 frozen PBMC samples.

Actiphage TB awarded US Patent grant for diagnostic kitPBD Biotech, developer of Actiphage® TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit.Grant of this US patent relating to Mycobacteria detecti...

Lyophilized PCR reaction bead reduces the cost of transport and extends shelf life for the test - News - PharmaTimes

Tuberculosis testing and treatment needs to happen close to the point of infection. PBD Biotech has developed a lyophilized PCR reaction bead for its Actiphage® blood test for active TB.

During the conference, we had the chance to catch up with some of the speakers to ask them about their work, as well as what they would be discussing at the 2023 BioInfet Conference.

Africa-based trials for blood test which detects risk of disease progression are due to begin - News - PharmaTimes

Tuberculosis disease and deaths increased during the COVID-19 pandemic*. This has created global demand for rapid tests such as Actiphage® (developed by PBD Biotech) to improve diagnosis of this preventable disease. In response to this need, PBD Biotech is announcing that it has appointed Dr Marie Roskrow to chair ...

PBD Biotech has developed a rapid screening blood test that shows promise for identifying people with human tuberculosis as well as a subgroup with pre-clinical infection at higher risk of developing the disease.

Inspirational Wythenshawe gran who fought off Covid-19 treated to pamper day for 100th birthday milestone Elsie Oates is the longest-serving customer at the Hair and Beauty Team at Manchester Colleges Northenden campus Dont miss a thing by getting the days biggest stories sent direct to your inboxInvalid EmailSomething went wrong, please try again later. Click here When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accorda...